Akanda Corp. (AKAN) vs Artelo Biosciences, Inc. (ARTL)
A side-by-side comparison of Akanda Corp. and Artelo Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
AKAN
Akanda Corp.
$1.89HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
ARTL
Artelo Biosciences, Inc.
$3.46HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — AKAN vs ARTL
growth of $100 · dividends reinvested · last 5yAKAN -100.0% (-91.8%/yr)ARTL -98.9% (-59.5%/yr)ARTL compounded faster over this window
Log scale — wide-divergence pair
AKAN ARTL
AKAN vs ARTL: by the numbers
- •ARTL is the larger company ($1M vs $61172 market cap).
- •Both run net losses; ARTL's is the smaller (0.00% vs -17690.19% net margin).
Metrics side by side
Valuation
| Metric | AKAN | ARTL |
|---|---|---|
| P/B ratio | N/A | 0.27 |
Profitability
| Metric | AKAN | ARTL |
|---|---|---|
| Gross margin | -60.46% | 0.00% |
| Operating margin | -1930.99% | 0.00% |
| Net margin | -17690.19% | 0.00% |
| ROE | N/A | -253.57% |
| ROIC | -242.09% | -219.36% |
Growth (annualized)
| Metric | AKAN | ARTL |
|---|---|---|
| Revenue CAGR (5Y) | 162.75% | N/A |
| Total return CAGR (5Y) | N/A | -64.27% |
Go deeper
Dig into the metrics
Akanda ROEArtelo Biosciences ROEAkanda operating marginArtelo Biosciences operating marginAkanda revenue growthArtelo Biosciences revenue growthAkanda free cash flowArtelo Biosciences free cash flow
Akanda & Artelo Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.